Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385611![]() (US10287292, Compound 1.013) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385626![]() (US10287292, Compound 1.021) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385629![]() (US10287292, Compound 1.023) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385717![]() (US10287292, Compound 1.029) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385819![]() (US10287292, Compound 1.035) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385880![]() (US10287292, Compound 1.058) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385884![]() (US10287292, Compound 1.062) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385892![]() (US10287292, Compound 1.070) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385898![]() (US10287292, Compound 1.076) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385914![]() (US10287292, Compound 1.092) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385915![]() (US10287292, Compound 1.093) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385921![]() (US10287292, Compound 1.099) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385928![]() (US10287292, Compound 1.106) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385929![]() (US10287292, Compound 1.107) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385932![]() (US10287292, Compound 1.110) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385936![]() (US10287292, Compound 1.114) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385939![]() (US10287292, Compound 1.117) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385945![]() (US10287292, Compound 1.123) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385951![]() (US10287292, Compound 1.129) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385597![]() (US10287292, Compound 1.001) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385743![]() (US10287292, Compound 1.031) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385805![]() (US10287292, Compound 1.032) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385864![]() (US10287292, Compound 1.042) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385873![]() (US10287292, Compound 1.051) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385882![]() (US10287292, Compound 1.060) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385889![]() (US10287292, Compound 1.067) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385895![]() (US10287292, Compound 1.073) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385904![]() (US10287292, Compound 1.082) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385912![]() (US10287292, Compound 1.090) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385915![]() (US10287292, Compound 1.093) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385918![]() (US10287292, Compound 1.096) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385922![]() (US10287292, Compound 1.100) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385927![]() (US10287292, Compound 1.105) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385930![]() (US10287292, Compound 1.108) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385931![]() (US10287292, Compound 1.109) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385933![]() (US10287292, Compound 1.111) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385935![]() (US10287292, Compound 1.113) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385937![]() (US10287292, Compound 1.115) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385938![]() (US10287292, Compound 1.116) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385946![]() (US10287292, Compound 1.124) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385950![]() (US10287292, Compound 1.128) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385950![]() (US10287292, Compound 1.128) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385619![]() (US10287292, Compound 1.017) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385625![]() (US10287292, Compound 1.020) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385859![]() (US10287292, Compound 1.037) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385867![]() (US10287292, Compound 1.045) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385872![]() (US10287292, Compound 1.050) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385876![]() (US10287292, Compound 1.054) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385898![]() (US10287292, Compound 1.076) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385901![]() (US10287292, Compound 1.079) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385903![]() (US10287292, Compound 1.081) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385910![]() (US10287292, Compound 1.088) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385910![]() (US10287292, Compound 1.088) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385917![]() (US10287292, Compound 1.095) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385939![]() (US10287292, Compound 1.117) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385940![]() (US10287292, Compound 1.118) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385944![]() (US10287292, Compound 1.122) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385947![]() (US10287292, Compound 1.125) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385949![]() (US10287292, Compound 1.127) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385599![]() (US10287292, Compound 1.003) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385861![]() (US10287292, Compound 1.039) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385862![]() (US10287292, Compound 1.040) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385870![]() (US10287292, Compound 1.048) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385874![]() (US10287292, Compound 1.052) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385875![]() (US10287292, Compound 1.053) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385887![]() (US10287292, Compound 1.065) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385901![]() (US10287292, Compound 1.079) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385911![]() (US10287292, Compound 1.089) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385914![]() (US10287292, Compound 1.092) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385918![]() (US10287292, Compound 1.096) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385920![]() (US10287292, Compound 1,098) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385937![]() (US10287292, Compound 1.115) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385940![]() (US10287292, Compound 1.118) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385946![]() (US10287292, Compound 1.124) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385948![]() (US10287292, Compound 1.126) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385606![]() (US10287292, Compound 1.009) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385627![]() (US10287292, Compound 1.022) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385630![]() (US10287292, Compound 1.024) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385860![]() (US10287292, Compound 1.038) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385890![]() (US10287292, Compound 1.068) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385891![]() (US10287292, Compound 1.069) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385893![]() (US10287292, Compound 1.071) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385902![]() (US10287292, Compound 1,080) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385906![]() (US10287292, Compound 1.084) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385906![]() (US10287292, Compound 1.084) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385907![]() (US10287292, Compound 1.085) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385913![]() (US10287292, Compound 1.091) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385916![]() (US10287292, Compound 1.094) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385919![]() (US10287292, Compound 1.097) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385924![]() (US10287292, Compound 1.102) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385943![]() (US10287292, Compound 1.121) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385947![]() (US10287292, Compound 1.125) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385602![]() (US10287292, Compound 1.006) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385610![]() (US10287292, Compound 1.012) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385614![]() (US10287292, Compound 1.014) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385818![]() (US10287292, Compound 1.034) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385877![]() (US10287292, Compound 1.055) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385886![]() (US10287292, Compound 1.064) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385888![]() (US10287292, Compound 1.066) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385894![]() (US10287292, Compound 1.072) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385911![]() (US10287292, Compound 1.089) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385913![]() (US10287292, Compound 1.091) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385923![]() (US10287292, Compound 1.101) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385926![]() (US10287292, Compound 1.104) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385934![]() (US10287292, Compound 1.112) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385936![]() (US10287292, Compound 1.114) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385617![]() (US10287292, Compound 1.015) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385618![]() (US10287292, Compound 1.016) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385623![]() (US10287292, Compound 1.019) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385871![]() (US10287292, Compound 1.049) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385896![]() (US10287292, Compound 1.074) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385899![]() (US10287292, Compound 1.077) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385900![]() (US10287292, Compound 1.078) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385905![]() (US10287292, Compound 1.083) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385907![]() (US10287292, Compound 1.085) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385917![]() (US10287292, Compound 1.095) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385919![]() (US10287292, Compound 1.097) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385920![]() (US10287292, Compound 1,098) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385921![]() (US10287292, Compound 1.099) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385924![]() (US10287292, Compound 1.102) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385942![]() (US10287292, Compound 1.120) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385942![]() (US10287292, Compound 1.120) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385943![]() (US10287292, Compound 1.121) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385945![]() (US10287292, Compound 1.123) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385948![]() (US10287292, Compound 1.126) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385631![]() (US10287292, Compound 1.025) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385633![]() (US10287292, Compound 1.026) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385699![]() (US10287292, Compound 1.028) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385738![]() (US10287292, Compound 1.030) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385823![]() (US10287292, Compound 1.036) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385863![]() (US10287292, Compound 1.041) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385866![]() (US10287292, Compound 1.044) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385868![]() (US10287292, Compound 1.046) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385879![]() (US10287292, Compound 1.057) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385881![]() (US10287292, Compound 1.059) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385899![]() (US10287292, Compound 1.077) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385900![]() (US10287292, Compound 1.078) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385912![]() (US10287292, Compound 1.090) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385916![]() (US10287292, Compound 1.094) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385925![]() (US10287292, Compound 1.103) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385935![]() (US10287292, Compound 1.113) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385941![]() (US10287292, Compound 1.119) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385944![]() (US10287292, Compound 1.122) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385949![]() (US10287292, Compound 1.127) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385951![]() (US10287292, Compound 1.129) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385905![]() (US10287292, Compound 1.083) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385930![]() (US10287292, Compound 1.108) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385925![]() (US10287292, Compound 1.103) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385883![]() (US10287292, Compound 1.061) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385600![]() (US10287292, Compound 1.004) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385933![]() (US10287292, Compound 1.111) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385929![]() (US10287292, Compound 1.107) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385903![]() (US10287292, Compound 1.081) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385607![]() (US10287292, Compound 1.010) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385928![]() (US10287292, Compound 1.106) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385941![]() (US10287292, Compound 1.119) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385927![]() (US10287292, Compound 1.105) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385885![]() (US10287292, Compound 1.063) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385897![]() (US10287292, Compound 1.075) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385902![]() (US10287292, Compound 1,080) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385934![]() (US10287292, Compound 1.112) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385938![]() (US10287292, Compound 1.116) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385908![]() (US10287292, Compound 1.086) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385923![]() (US10287292, Compound 1.101) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385603![]() (US10287292, Compound 1.007) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385696![]() (US10287292, Compound 1.027) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385908![]() (US10287292, Compound 1.086) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385931![]() (US10287292, Compound 1.109) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385932![]() (US10287292, Compound 1.110) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385604![]() (US10287292, Compound 1.008) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385817![]() (US10287292, Compound 1.033) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385878![]() (US10287292, Compound 1.056) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385904![]() (US10287292, Compound 1.082) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385909![]() (US10287292, Compound 1.087) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385909![]() (US10287292, Compound 1.087) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description Target compounds can be tested to determine their ability to bind with CXCR7 sites on MCF-7 and/or MDA-MB-435S CXCR7 transfected cells. Efficiency-ma... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385598![]() (US10287292, Compound 1.002) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385865![]() (US10287292, Compound 1.043) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385897![]() (US10287292, Compound 1.075) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385622![]() (US10287292, Compound 1.018) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385869![]() (US10287292, Compound 1.047) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385926![]() (US10287292, Compound 1.104) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385609![]() (US10287292, Compound 1.011) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385601![]() (US10287292, Compound 1.005) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM385922![]() (US10287292, Compound 1.100) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >2.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
ChemoCentryx, Inc. US Patent | Assay Description In order to more properly assess the binding efficacy of the compounds, radioligand binding assays were carried out in the presence of 100% human ser... | US Patent US10287292 (2019) BindingDB Entry DOI: 10.7270/Q2KS6TV7 | |||||||||||
More data for this Ligand-Target Pair |